Patient expectations and choices are increasingly important in healthcare. However safe and effective a drug is in clinical trials, if patients choose not to take it in the real world, then biopharma, patients and healthcare systems all lose out. Discrete Choice Experiments offers a solution.

‘Discrete Choice Experiments’ (DCE) can help you find out which characteristics patients really value. These help companies to truly understand their patients’ preferences by getting patients to pick the best and worst options from a set of sample drug profiles.

By working in partnership with QuintilesIMS and IGES, learn more about how DCEs can help you create drugs that patients will take and payers will value.